Crossmark

Intravenous tocilizumab in the management of rheumatoid arthritis: Clinical practice findings from a 6-month international, multicentre, observational study in Central America and the Caribbean

Crossref DOI link: https://doi.org/10.1016/j.rcreue.2020.05.004

Published Print: 2020-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ortega-Gómez, Alma-Xochitl

Sanabria-Castro, Alfredo

Alpízar-Campos, Raúl

Guerra-Bautista, Generoso

Méndez-Rodríguez, José-Alexis

Muñoz-Louis, Roberto

Chávez-Pérez, Nilmo

Cajas-Melgar, Erwin-Stuardo

González-Sevillano, Edgardo

López-Barquero, Alejandra
License Information

Text and Data Mining valid from 2020-10-01
More Information

This article is maintained by: Elsevier

Article Title: Intravenous tocilizumab in the management of rheumatoid arthritis: Clinical practice findings from a 6-month international, multicentre, observational study in Central America and the Caribbean

Journal Title: Revista Colombiana de Reumatología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rcreue.2020.05.004

Content Type: article

Copyright: © 2020 Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below